$Esperion Therapeutics Inc.(ESPR) Exploded +55.50%: High-Volume Breakout Tests $3.11 Resistance

Latest Close Data: ESPR closed at $3.11 on 2026-05-01, surging +55.50% from the previous close. The price is now about 25% below its 52-week high of $4.17.

Core Market Drivers: The massive single-day move appears driven by significant institutional and retail buying interest, evidenced by a huge volume of 182M shares and a turnover rate of 70.82%. No specific news was provided, but the technical breakout itself is a major driver.

Technical Analysis: The surge was accompanied by extreme volume (Volume Ratio: 29.21). The 6-day RSI rocketed to 91.85, indicating severely overbought conditions. The MACD (12,26,9) histogram turned strongly positive at +0.188, confirming a powerful bullish momentum shift.

Key Price Levels:

  • Immediate Pivot/Resistance: $3.11 (yesterday's identified resistance)

  • Primary Support: $1.91

  • Strong Resistance: $4.17 (52-week high)

Valuation Perspective: The stock trades at a TTM P/S of 1.98, while the forward P/E of 60.81 is significantly above its historical average of -34.70, suggesting the market is pricing in high future growth expectations.

Analyst Targets: According to 7 analysts, the average price target is $3.51 (approx. +13% upside), with a range of $1.78 to $5.00. The consensus rating leans heavily towards "Hold".

Weekly Outlook: Expect volatility and potential consolidation after the parabolic move. Immediate focus is on whether the price can hold above the $3.11 pivot. A successful break could target the $3.50-$4.00 zone. Failure may see a retest of the $2.50-$2.80 area.

Risk Disclaimer: This analysis is for informational purposes only and not financial advice. Trading involves significant risk. The stock is extremely overbought (RSI > 90), which presents a high risk of a sharp pullback. Please conduct your own research.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Top
  • Latest
  • Kenwen
    ·00:20
    Great article, would you like to share it?
    Reply
    Report